
Bioventus uses cash flow to cut debt and expand, boosting growth outlook and valuation appeal.
Bioventus is leveraging cash generated from its established orthopedic products to reduce debt and fund commercial expansion. The company has improved its financing terms by extending its term loan maturity to 2030 and reducing its interest margin by...





